US Broker Ratings

Perrigo Company plc (PRGO) Stock Analysis: Evaluating a 46.65% Upside Potential for Healthcare Investors

Perrigo Company plc (NYSE: PRGO) is an intriguing player in the healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry. Headquartered in Dublin, Ireland, Perrigo offers a..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Biotech Innovator with 73% Potential Upside

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering biotechnology company headquartered in Cambridge, Massachusetts, is capturing investor attention with its promising genetic medicine pipeline and significant potential upside. As of the..

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring 41.81% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) operates at the intersection of innovation and healthcare within the medical devices industry. As a U.S.-based company with a market cap of $851.56 million,..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook and Potential 39.77% Upside

Aveanna Healthcare Holdings Inc (AVAH) is capturing the attention of investors with its promising potential upside of nearly 40%. Based in Atlanta, Georgia, Aveanna operates as a diversified home care..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 29.75% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.37 billion, Azenta stands out as..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A 194% Upside Potential in the Biotech Sector

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is drawing significant attention from investors with its impressive potential upside of 194.52%, according to recent analyst ratings. As a biopharmaceutical company specializing in treatments..

SS Innovations International (SSII) Stock Analysis: Examining an Impressive 192.5% Revenue Growth in the Medical Device Sector

SS Innovations International Inc. (SSII), a burgeoning force in the healthcare sector, operates in the medical devices industry, showcasing revolutionary advancements in surgical robotics. Headquartered in Gurugram, India, the company..

Disc Medicine, Inc. (IRON) Stock Analysis: Evaluating a 66% Upside Potential in Biotechnology

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline of treatments aimed at serious hematologic diseases. Headquartered in Watertown, Massachusetts,..

Kestra Medical Technologies (KMTS) Investor Outlook: 53% Revenue Surge and 8% Upside Potential

Investors looking for opportunities in the healthcare sector might want to pay close attention to Kestra Medical Technologies, Ltd. (KMTS). This innovative company, headquartered in Kirkland, Washington, is making waves..

Privia Health Group, Inc. (PRVA) Investor Outlook: Unpacking a 44.48% Potential Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent name in the healthcare sector, is capturing investor attention with a striking potential upside of 44.48%. Operating as a physician-enablement company, Privia..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 54.7% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV), a key player in the healthcare sector, offers a compelling opportunity for investors looking to tap into the Medicare Advantage market. With a market..

PTC Therapeutics, Inc. (PTCT) Investor Outlook: Exploring a 19% Potential Upside

In the ever-evolving landscape of biotechnology, PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out as a key player with a focus on rare disorders. Headquartered in Warren, New Jersey, PTC Therapeutics..

Addus HomeCare Corporation (ADUS) Stock Analysis: 35.96% Upside Potential Sparks Investor Interest

Addus HomeCare Corporation (NASDAQ: ADUS) stands out as a compelling opportunity in the healthcare sector, particularly within the medical care facilities industry. With a current market capitalization of $1.92 billion,..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: With a Potential Upside of 243.92%, Is This Healthcare Stock a Hidden Gem?

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnology company renowned for its innovation in developing therapeutics for rare diseases, presents a compelling opportunity for investors seeking high-growth potential within the healthcare..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Evaluating a 24.68% Potential Upside for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling investment opportunity, especially for those looking to capitalize on its robust position in the healthcare sector. With a significant market cap..

Catalyst Pharmaceuticals (CPRX) Investor Outlook: A Promising 41.4% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of individual investors with its compelling investment proposition. This biopharmaceutical company, headquartered in Coral Gables, Florida, focuses on developing and commercializing..

BioLife Solutions (BLFS): Investor Outlook on a Healthcare Innovator With a 43% Potential Upside

Investors with an eye on the healthcare sector may find BioLife Solutions, Inc. (NASDAQ: BLFS) an intriguing opportunity. As a key player in the Medical Instruments & Supplies industry, BioLife..

Select Medical Holdings Corp (SEM): Analyst Consensus Indicates 17.65% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a prominent player in the healthcare sector, is positioned for intriguing growth potential. With a market capitalization of $1.94 billion, the company has carved..

Bausch Health Companies Inc. (BHC) Stock Analysis: Robust Free Cash Flow and Potential 24% Upside

Bausch Health Companies Inc. (NYSE: BHC) offers investors a unique proposition within the healthcare sector, particularly in the drug manufacturing industry. With its diversified portfolio spanning gastroenterology, neurology, dermatology, and..

Establishment Labs Holdings Inc (ESTA): Investor Outlook on a Healthcare Innovator with 19.77% Upside Potential

For investors seeking exposure to the burgeoning medical devices sector, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents an intriguing opportunity. Headquartered in Alajuela, Costa Rica, this healthcare company specializes in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds